1. Home
  2. ALT vs CMCL Comparison

ALT vs CMCL Comparison

Compare ALT & CMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • CMCL
  • Stock Information
  • Founded
  • ALT 1997
  • CMCL 1992
  • Country
  • ALT United States
  • CMCL Jersey
  • Employees
  • ALT N/A
  • CMCL N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • CMCL Precious Metals
  • Sector
  • ALT Health Care
  • CMCL Basic Materials
  • Exchange
  • ALT Nasdaq
  • CMCL Nasdaq
  • Market Cap
  • ALT 397.4M
  • CMCL 321.6M
  • IPO Year
  • ALT N/A
  • CMCL N/A
  • Fundamental
  • Price
  • ALT $4.19
  • CMCL $20.89
  • Analyst Decision
  • ALT Strong Buy
  • CMCL Strong Buy
  • Analyst Count
  • ALT 6
  • CMCL 1
  • Target Price
  • ALT $18.20
  • CMCL $21.00
  • AVG Volume (30 Days)
  • ALT 11.7M
  • CMCL 157.0K
  • Earning Date
  • ALT 08-07-2025
  • CMCL 08-11-2025
  • Dividend Yield
  • ALT N/A
  • CMCL 2.68%
  • EPS Growth
  • ALT N/A
  • CMCL N/A
  • EPS
  • ALT N/A
  • CMCL 1.28
  • Revenue
  • ALT $20,000.00
  • CMCL $190,568,000.00
  • Revenue This Year
  • ALT N/A
  • CMCL $20.99
  • Revenue Next Year
  • ALT $1,557,547.90
  • CMCL $0.56
  • P/E Ratio
  • ALT N/A
  • CMCL $15.83
  • Revenue Growth
  • ALT N/A
  • CMCL 29.36
  • 52 Week Low
  • ALT $2.90
  • CMCL $8.81
  • 52 Week High
  • ALT $11.16
  • CMCL $22.20
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.67
  • CMCL 60.88
  • Support Level
  • ALT $4.33
  • CMCL $20.14
  • Resistance Level
  • ALT $4.79
  • CMCL $22.20
  • Average True Range (ATR)
  • ALT 0.52
  • CMCL 0.88
  • MACD
  • ALT -0.16
  • CMCL -0.02
  • Stochastic Oscillator
  • ALT 26.92
  • CMCL 62.89

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About CMCL Caledonia Mining Corporation Plc

Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.

Share on Social Networks: